Interstitial Lung Disease Trial, Recruiting NCT07707245 Sponsor: Fondazione Don Carlo Gnocchi ETS Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT07707245
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older.
  • People who have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and are current or former smokers, and/or people diagnosed with Idiopathic Pulmonary Fibrosis (IPF) and are current or former smokers, and/or people diagnosed with a type of lung cancer called lung adenocarcinoma that can be treated with surgery (at certain stages).
  • People who are able to follow the study procedures and attend any required follow-up visits.

Who may not be able to join:

  • People who are unable or unwilling to give their formal consent to take part in the study.
  • People who have an active respiratory infection, or whose COPD or IPF is in a period of sudden worsening, at the time of joining the trial.
  • People who have, or have previously had, another form of cancer (other than a common type of non-serious skin cancer) that could affect the study results.
  • People who have recently taken or are currently taking certain medicines that suppress or reduce inflammation in the immune system, which could affect how the immune system is measured in the study (confirm with trial site regarding exact timeframes).
  • People with serious other health conditions — such as advanced heart failure or severe kidney or liver disease — that may affect life expectancy or the ability to complete the study.
  • People from whom the required blood samples cannot be collected, or whose blood samples are not of suitable quality for the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mario Clerici, MD, IRCCS Fondazione Don Carlo Gnocchi

Phone: +39024030801

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione Don Carlo Gnocchi ETS
Registry
ClinicalTrials.gov
Start date
22 April 2026
Est. completion
30 November 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Innate immunity; Genetic polymorphisms; Adaptive immunity; serum microRNAs; Forced Expiratory Volume in 1 second; VC; Total Lung Capacity; Inspiratory Capacity; Expiratory Reserve Volume; Residual Volume; Diffusing Capacity of the Lung for Carbon Monoxide / Alveolar Volume; Blood gas analysis - PaO2; Blood gas analysis - PaCO2; Test 6 minute walk

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov